Lantheus Holdings, Inc. Payments to Acquire Productive Assets
Lantheus Holdings, Inc. (LNTH) reported Payments to Acquire Productive Assets of $45.34 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2024-02-22
- Lantheus Holdings, Inc. payments to acquire productive assets for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. payments to acquire productive assets for the quarter ending 2023-09-30 was $0.00.
- Lantheus Holdings, Inc. payments to acquire productive assets for the quarter ending 2023-06-30 was $10.00M.
- Lantheus Holdings, Inc. payments to acquire productive assets for the quarter ending 2023-03-31 was $35.34M.
- Lantheus Holdings, Inc. payments to acquire productive assets for fiscal 2023 was $45.34M, a 82.56% decline from fiscal 2022.
- Lantheus Holdings, Inc. payments to acquire productive assets for fiscal 2022 was $260.00M.
- Lantheus Holdings, Inc. payments to acquire productive assets for fiscal 2021 was $0.00.
- Lantheus Holdings, Inc. payments to acquire productive assets for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 3 month as first filed | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 6 month as first filed | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 9 month as first filed | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $10.00M derived: sum of 3 quarters · filed 2024-02-22 | $45.34M 10-K · filed 2024-02-22 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $10.00M derived: sum of 2 quarters · filed 2023-11-02 | $45.34M 10-Q · filed 2023-11-02 | $305.35M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2023-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $45.34M 10-Q · filed 2023-08-03 | $305.35M derived: sum of 3 quarters · filed 2024-02-22 | $305.35M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2023-03-31 | $35.34M 10-Q · filed 2023-05-04 | $295.35M derived: sum of 2 quarters · filed 2024-02-22 | $295.35M derived: sum of 3 quarters · filed 2024-02-22 | $295.35M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-12-31 | $260.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $260.00M derived: sum of 2 quarters · filed 2024-02-22 | $260.00M derived: sum of 3 quarters · filed 2024-02-22 | $260.00M 10-K · filed 2024-02-22 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $13.62M 10-Q · filed 2022-11-03 | -$7.60M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $7.53M 10-Q · filed 2022-08-04 | -$7.60M derived: sum of 3 quarters · filed 2024-02-22 | -$5.18M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $3.19M 10-Q · filed 2022-04-29 | -$7.60M derived: sum of 2 quarters · filed 2024-02-22 | -$5.18M derived: sum of 3 quarters · filed 2024-02-22 | -$2.52M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | -$7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$5.18M derived: sum of 2 quarters · filed 2024-02-22 | -$2.52M derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | $12.14M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.08M derived: sum of 2 quarters · filed 2022-11-03 | $7.60M 10-Q · filed 2022-11-03 | -$1.09M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.18M 10-Q · filed 2022-08-04 | -$3.51M derived: sum of 3 quarters · filed 2023-02-23 | $223.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $2.52M 10-Q · filed 2022-04-29 | -$6.17M derived: sum of 2 quarters · filed 2023-02-23 | -$2.43M derived: sum of 3 quarters · filed 2023-02-23 | -$178.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$4.95M derived: sum of 2 quarters · filed 2023-02-23 | -$2.70M derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | $12.47M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $5.99M derived: sum of 2 quarters · filed 2021-11-04 | $8.69M 10-Q · filed 2021-11-04 | $13.43M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $4.95M 10-Q · filed 2021-07-28 | $9.69M derived: sum of 3 quarters · filed 2022-02-24 | $13.03M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $2.70M 10-Q · filed 2021-05-04 | $7.44M derived: sum of 2 quarters · filed 2022-02-24 | $10.78M derived: sum of 3 quarters · filed 2022-02-24 | $14.21M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $8.08M derived: sum of 2 quarters · filed 2022-02-24 | $11.51M derived: sum of 3 quarters · filed 2022-02-24 | $22.06M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.77M derived: sum of 2 quarters · filed 2020-11-05 | $17.32M 10-Q · filed 2020-11-05 | $24.69M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $13.98M 10-Q · filed 2020-07-31 | $21.35M derived: sum of 3 quarters · filed 2021-02-25 | $26.36M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $10.55M 10-Q · filed 2020-04-30 | $17.92M derived: sum of 2 quarters · filed 2021-02-25 | $22.92M derived: sum of 3 quarters · filed 2021-02-25 | $28.55M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $12.37M derived: sum of 2 quarters · filed 2021-02-25 | $18.00M derived: sum of 3 quarters · filed 2021-02-25 | $20.13M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $10.63M derived: sum of 2 quarters · filed 2019-10-31 | $12.77M 10-Q · filed 2019-10-31 | $18.72M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $5.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $7.76M 10-Q · filed 2019-07-25 | $13.71M derived: sum of 3 quarters · filed 2020-02-25 | $17.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $2.13M 10-Q · filed 2019-04-30 | $8.09M derived: sum of 2 quarters · filed 2020-02-25 | $11.38M derived: sum of 3 quarters · filed 2020-02-25 | $14.78M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $9.24M derived: sum of 2 quarters · filed 2020-02-25 | $12.64M derived: sum of 3 quarters · filed 2020-02-25 | $17.54M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $6.69M derived: sum of 2 quarters · filed 2018-10-30 | $11.59M 10-Q · filed 2018-10-30 | $14.01M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $8.30M 10-Q · filed 2018-08-01 | $10.72M derived: sum of 3 quarters · filed 2019-02-20 | $13.31M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $4.90M 10-Q · filed 2018-05-02 | $7.32M derived: sum of 2 quarters · filed 2019-02-20 | $9.91M derived: sum of 3 quarters · filed 2019-02-20 | $10.64M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $5.01M derived: sum of 2 quarters · filed 2019-02-20 | $5.75M derived: sum of 3 quarters · filed 2019-02-20 | $7.40M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $3.32M derived: sum of 2 quarters · filed 2017-11-02 | $4.98M 10-Q · filed 2017-11-02 | $9.71M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $2.39M 10-Q · filed 2017-08-01 | $7.12M derived: sum of 3 quarters · filed 2018-02-26 | $9.43M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $1.65M 10-Q · filed 2017-05-02 | $6.38M derived: sum of 2 quarters · filed 2018-02-26 | $8.69M derived: sum of 3 quarters · filed 2018-02-26 | $11.30M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.04M derived: sum of 2 quarters · filed 2018-02-26 | $9.65M derived: sum of 3 quarters · filed 2018-02-26 | $13.15M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $4.92M derived: sum of 2 quarters · filed 2016-11-01 | $8.42M 10-Q · filed 2016-11-01 | $11.25M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $6.11M 10-Q · filed 2016-08-04 | $8.95M derived: sum of 3 quarters · filed 2017-02-23 | $10.77M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $3.50M 10-Q · filed 2016-05-03 | $6.33M derived: sum of 2 quarters · filed 2017-02-23 | $8.15M derived: sum of 3 quarters · filed 2017-02-23 | |||||
| 2014-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.66M derived: sum of 2 quarters · filed 2017-02-23 | $8.14M 10-K · filed 2017-02-23 | |||||
| 2014-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $5.30M 10-Q · filed 2015-11-04 | ||||||
| 2014-06-30 | $3.48M 10-Q · filed 2015-08-05 | |||||||
| 2013-12-31 | $5.01M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |